Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots ; volume:16 ; number:1 ; day:26 ; month:7 ; year:2016 ; pages:1-5 ; date:12.2016
BMC ophthalmology ; 16, Heft 1 (26.7.2016), 1-5, 12.2016
- Creator
-
Pece, Alfredo
- Contributor
-
Allegrini, Davide
Kontadakis, Stelios
Querques, Giuseppe
Rossetti, Luca
SpringerLink (Online service)
- DOI
-
10.1186/s12886-016-0307-0
- URN
-
urn:nbn:de:1111-2016072737660
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pece, Alfredo
- Allegrini, Davide
- Kontadakis, Stelios
- Querques, Giuseppe
- Rossetti, Luca
- SpringerLink (Online service)
Other Objects (12)
Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Inflammasome activation aggravates choroidal neovascularization
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
A 5-Year-Old Case of Choroidal Neovascularization in Enhanced S-Cone Syndrome Treated with Ranibizumab
Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Inflammasome activation aggravates choroidal neovascularization
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
A 5-Year-Old Case of Choroidal Neovascularization in Enhanced S-Cone Syndrome Treated with Ranibizumab
Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Inflammasome activation aggravates choroidal neovascularization
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration